Related Experiment Video
Updated: Jan 20, 2026

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
Published on: August 23, 2022
Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric
Anindya Bhattacharya1, Marc Ceusters2
1Neuroscience Therapeutic Area, Janssen R&D LLC., 3210 Merryfield Row, San Diego, CA, 92121, USA. abhatta2@its.jnj.com.
No abstract available in PubMed .
Related Concept Videos
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
07:31Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
06:19Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
08:43Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
03:30Inducing Penetrating Traumatic Brain Injury in Adult Drosophila Flies
02:12Induction of Neuroinflammation in Mice via Injection of Alpha-Synuclein Fibrils
